To make prescription drugs more affordable for all Americans. CSRxP advocates for bipartisan solutions that hold pharmaceutical companies accountable for out-of-control drug prices and provide more affordable choices for patients. We believe in market-based reforms that address the underlying causes of high drug prices in the U.S. through increased transparency, competition, and value.
Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold Drug Companies Accountable Would Lower Prices And Increase Innovation For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a new study from Avik Roy and Gregg Girvan of the…
Brand Name Drug Maker AstraZeneca Aggressively Raised Prices In The Middle Of A Pandemic, Even While Receiving Hundreds Of Millions In Taxpayer Funding Vaccine Maker Got $1 Billion From Taxpayers.
Report Finds Just Five Instances Of Product Hopping Sticks Americans With $4.7 Billion Price Tag In case you missed it, a new study by Alex Brill of Matrix Global Advisors (MGA), commissioned by the…
Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower Drug Prices, While Increasing Medicare Premiums For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]
Drug prices are out-of-control. At a time when one-in-four Americans cannot afford their medication, Big Pharma is posting record profits – doubling down on monopolistic tactics to game America’s patent system, prevent generic and biosimilar competition and patient choice and pad their bottom lines.
No patient should ever have to choose between paying for their daily needs or taking the medicine they need to live. Every person deserves access to the medications they need at a price they can afford, especially those who can least afford them.
Americans deserve choice and control over their health. We must all work together to promote competition and increase access to high-quality, affordable treatments and cures for patients. It’s time for real solutions that can deliver more choices, more competition, and lower drug prices by addressing the root causes of price gouging:
Transparency: Patients deserve open and honest drug pricing – clear information about the true costs of treatment, how the price of medication is set, and how much it actually costs to bring new drugs to market so they can make more informed decisions about their medications, particularly those with high price tags.
Accountability: When Big Pharma is able to prevent competition and maintain a monopoly on medicines, they can set any price they want. It’s time for Congress to step in and hold Big Pharma accountable for out-of-control drug prices, unchecked price gouging, and rampant patent abuse.
Competition: Big Pharma’s ability to raise the price of a drug overnight or allow the prices of old drugs rise to shadow the prices of comparable new drugs, means we are not operating in a healthy, functioning market. The market can work, but right now it is broken. Bringing competition into the prescription drug market will give consumers more choices and more control – resulting in lower prices and greater access.
Value: Patients deserve reliable information regarding whether a drug’s “therapeutic outcome” – or its health benefit – is in line with its price. That information will be critical to moving America’s prescription drug market toward a system that empowers doctors and patients to choose medications based on the value they provide – not a “value” set by drug manufacturers.
The Campaign for Sustainable Rx Pricing (CSRxP) is a broad-based coalition of leaders – physicians, nurses, hospitals, consumers, health plans, PBMs, pharmacists, and businesses – promoting bipartisan, market-based solutions to lower drug prices in America.
This message is only visible to admins:
Unable to display Facebook posts